FDA Orange Book · active-ingredient family
Fluocinolone acetonide; hydroquinone; tretinoin
Fluocinolone acetonide; hydroquinone; tretinoin is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:TRI-LUMA · NDA 021112
1
Brand (NDA)
0
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · cream
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| TRI-LUMARLD | GALDERMA LABS LP | NDA 021112 | — | Jan 18, 2002 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Fluocinolone acetonide; hydroquinone; tretinoin — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.
